Physician profile
Stuart T Smith
NPI 1396281416
$307.22
in general payments reported to CMS, 2019-2025
9 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $67.93 | 2025 | |
| Medtronic, INC. | $49.61 | 2025 | Minimed 780g |
| Novo Nordisk INC | $44.09 | 2025 | Wegovy |
| Beta Bionics, INC. | $41.90 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Tandem Diabetes Care, INC. | $28.75 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $26.64 | 2025 | Korlym |
| Acella Pharmaceuticals, LLC | $17.20 | 2025 | NP Thyroid 60 |
| Abbvie INC. | $15.57 | 2025 | |
| Paratek Pharmaceuticals, INC. | $15.53 | 2025 | Xhance, Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.